Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.54
-0.07 (-0.81%)
At close: Sep 29, 2026, 4:00 PM EDT
8.84
+0.30 (3.51%)
After-hours: Sep 29, 2026, 7:50 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $747.23 million as of September 29, 2026. Its market cap has increased by 14.48% in one year.
Market Cap
747.23M
Enterprise Value
289.82M
1-Year Change
14.48%
Ranking
Category
Stock Price
$8.54
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $747.23M, a decrease of -58.36%. That is a compound annual growth rate of -13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 747.23M | -62.00% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 798.70M |
| Obsidian Therapeutics | 794.40M |
| Immix Biopharma | 784.79M |
| Solid Biosciences | 781.67M |
| Gyre Therapeutics | 779.35M |
| Achieve Life Sciences | 775.88M |
| Inventiva | 766.06M |
| Design Therapeutics | 758.49M |